Rare lephants
Screener

Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Sep 10, 2026
8-K Aug 28, 2026 8-K
S-3 Aug 28, 2026 S-3
8-K Aug 12, 2026 8-K
10-Q Aug 12, 2026 10-Q
4 Aug 6, 2026 4
3 Aug 6, 2026 3
8-K Jul 14, 2026 8-K
4 Jun 25, 2026 4
4 Jun 25, 2026 4
4 Jun 25, 2026 4
4 Jun 25, 2026 4
4 Jun 25, 2026 4
4 Jun 25, 2026 4
4 Jun 25, 2026 4
8-K Jun 25, 2026 8-K
S-8 Jun 23, 2026 S-8
8-K Jun 22, 2026 8-K
10-Q May 13, 2026 10-Q
8-K May 13, 2026 8-K
4 May 6, 2026 4
ARS Apr 27, 2026 ARS
DEFA14A Apr 27, 2026 DEFA14A
DEF 14A Apr 27, 2026 DEF 14A
PRE 14A Apr 13, 2026 PRE 14A
← Newer Page 1 of 21 · 513 filings Older →